» Articles » PMID: 18757750

The Oxazolidinone Antibiotics Perturb the Ribosomal Peptidyl-transferase Center and Effect TRNA Positioning

Overview
Specialty Science
Date 2008 Sep 2
PMID 18757750
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

The oxazolidinones represent the first new class of antibiotics to enter into clinical usage within the past 30 years, but their binding site and mechanism of action has not been fully characterized. We have determined the crystal structure of the oxazolidinone linezolid bound to the Deinococcus radiodurans 50S ribosomal subunit. Linezolid binds in the A site pocket at the peptidyltransferase center of the ribosome overlapping the aminoacyl moiety of an A-site bound tRNA as well as many clinically important antibiotics. Binding of linezolid stabilizes a distinct conformation of the universally conserved 23S rRNA nucleotide U2585 that would be nonproductive for peptide bond formation. In conjunction with available biochemical data, we present a model whereby oxazolidinones impart their inhibitory effect by perturbing the correct positioning of tRNAs on the ribosome.

Citing Articles

Black tongue caused by linezolid in children: One case report and literature review.

Zhang C, Shen H, Zhang J, Xu L, Yan M, Liu C IDCases. 2025; 39:e02181.

PMID: 39995819 PMC: 11847726. DOI: 10.1016/j.idcr.2025.e02181.


Diversity in Adaptive Evolution of Methicillin-Resistant Clinical Isolates Under Exposure to Continuous Linezolid Stress in vitro.

Han T, Jia T, Wang J Infect Drug Resist. 2025; 18:819-834.

PMID: 39958981 PMC: 11829590. DOI: 10.2147/IDR.S493139.


Context-specific inhibition of mitochondrial ribosomes by phenicol and oxazolidinone antibiotics.

Bibel B, Raskar T, Couvillion M, Lee M, Kleinman J, Takeuchi-Tomita N Nucleic Acids Res. 2025; 53(3).

PMID: 39907106 PMC: 11795202. DOI: 10.1093/nar/gkaf046.


Linezolid-Induced Lactic Acidosis Presenting As Acute Cholecystitis: A Case Report and Systematic Review.

Akter F, Bozell H, Neumann T, Chung C Cureus. 2024; 16(10):e70794.

PMID: 39493130 PMC: 11531368. DOI: 10.7759/cureus.70794.


Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics.

Krawczyk S, Lesniczak-Staszak M, Gowin E, Szaflarski W Biomolecules. 2024; 14(10).

PMID: 39456196 PMC: 11505993. DOI: 10.3390/biom14101263.


References
1.
Harms J, Schlunzen F, Fucini P, Bartels H, Yonath A . Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. BMC Biol. 2004; 2:4. PMC: 400760. DOI: 10.1186/1741-7007-2-4. View

2.
Leach K, Swaney S, Colca J, McDonald W, Blinn J, Thomasco L . The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell. 2007; 26(3):393-402. DOI: 10.1016/j.molcel.2007.04.005. View

3.
Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

4.
Connell S, Topf M, Qin Y, Wilson D, Mielke T, Fucini P . A new tRNA intermediate revealed on the ribosome during EF4-mediated back-translocation. Nat Struct Mol Biol. 2009; 15(9):910-5. DOI: 10.1038/nsmb.1469. View

5.
Lin A, Murray R, Vidmar T, Marotti K . The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother. 1997; 41(10):2127-31. PMC: 164081. DOI: 10.1128/AAC.41.10.2127. View